INCIPOD-CV 325
Indication
InciPod CV 325 tablets, containing Cefpodoxime Proxetil (200mg) and Potassium Clavulanate (125mg), are a potent treatment for respiratory tract infections. This combination leverages the antibacterial efficacy of Cefpodoxime Proxetil and the beta-lactamase inhibiting properties of Clavulanic Acid. Cefpodoxime Proxetil disrupts bacterial cell wall synthesis, crucial for bacterial survival, while Clavulanic Acid prevents the breakdown of the antibiotic by beta-lactamase enzymes, thereby enhancing its effectiveness against a broad spectrum of bacteria.
These tablets, such as InciPod CV 325, are specifically formulated to combat infections like bronchitis, pneumonia, and sinusitis effectively. By inhibiting resistance mechanisms, they ensure swift recovery and minimize complications associated with respiratory infections. Available for purchase online, InciPod CV 325 tablets are manufactured, supplied, and exported by reputable pharmaceutical companies committed to delivering quality healthcare solutions.
The synergy between Cefpodoxime Proxetil and Potassium Clavulanate in InciPod CV 325 tablets underscores their role as a reliable treatment option, addressing both bacterial diversity and resistance challenges in respiratory tract infections. This combination not only targets pathogens effectively but also helps mitigate the risk of antibiotic resistance, making it a preferred choice among healthcare providers for managing respiratory infections comprehensively.
Contraindication
Nausea, Diarrhoea, Headache, Rash, Abdominal pain, vaginal infection, fungal infection of vaginaStorage
Cool & Dry Place
Inquire Now